Perception prevalence of the relationship between PID and infertility amongst women of reproductive age: A Nigerian study Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

June 27, 2025

  • Women’s Health
    Women’s Health

    Women’s health, a vital aspect of medical science, encompasses various conditions unique to women’s physiological makeup. Historically, women were often excluded from clinical research, leading to a gap in understanding the intricacies of women’s health needs. However, recent advancements have highlighted the significant role that the microbiome plays in these conditions, offering new insights and potential therapies. MicrobiomeSignatures.com is at the forefront of exploring the microbiome signature of each of these conditions to unravel the etiology of these diseases and develop targeted microbiome therapies.

  • Female Infertility
    Female Infertility

    Female infertility is a multifactorial condition affecting 10-15% of women of reproductive age, often caused by underlying conditions like Bacterial Vaginosis (BV), PCOS, Endometriosis, and Pelvic Inflammatory Disease (PID). Microbiome-targeted interventions (MBTIs) offer a promising approach to restoring balance, improving fertility outcomes, and addressing root causes.

  • Pelvic Inflammatory Disease (PID)
    Pelvic Inflammatory Disease (PID)

    Pelvic Inflammatory Disease (PID) is a complex interplay between pathogens, immune responses, and microbial communities. As research continues to uncover the microbiome's role in reproductive health, microbiome-targeted interventions (MBTIs) such as probiotics, prebiotics, and transplants are redefining how we prevent and treat PID. This page dives deep into these innovations, offering a glimpse into the future of personalized, biologically informed women’s healthcare.

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

Last Updated: 2025

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What was studied?

This cross-sectional study investigated the perception prevalence of the relationship between pelvic inflammatory disease (PID) and infertility among women of reproductive age in Rivers State, Nigeria. The primary aim was to assess awareness and understanding of the established link between PID, an ascending genital tract infection often caused by sexually transmitted infections (STIs) like Chlamydia trachomatis, and infertility, which is recognized globally as a major public health concern. The study evaluated awareness levels regarding PID, infertility, and their interrelationship, with particular interest in how education and age might influence these perceptions. Data were collected from women attending an enlightenment campaign hosted by the Mother and Baby Care Global Foundation and analyzed using SPSS.

Who was studied?

The study population comprised 250 women of reproductive age (20–49 years) who participated in a local health campaign in Port Harcourt, Rivers State, Nigeria. The mean age was 24 ± 4 years, with 46% aged 20–29, 34% aged 30–39, and 20% aged 40–49. Educational attainment was high in this cohort, with 80% holding tertiary qualifications and the remaining 20% having secondary education. All participants provided informed consent, and those under 15 or over 49 years were excluded from the study.

Most important findings

Despite high educational status among participants, only 30% were aware of PID and 45% were aware of infertility. Notably, only 10% recognized the relationship between PID and infertility, a figure that is low given the well-documented association between these conditions. The highest perception prevalence of the PID-infertility link was observed in women aged 30–39 years (6%). Microbiologically, the study reinforces that Chlamydia trachomatis and Neisseria gonorrhoeae are the primary pathogens implicated in PID, with Chlamydia infection alone accounting for up to 45% of tubal infertility in referenced literature. Approximately 85% of PID cases globally are attributable to STIs. The low perception prevalence found here suggests a significant gap in patient awareness, which is critical given the preventable nature of many PID-related infertility cases.

Key implications

The findings highlight an urgent need for targeted public health education and community-based interventions to raise awareness about PID and its reproductive consequences. Despite high levels of formal education, knowledge gaps persist, underlining that educational campaigns must be tailored and recurrent. From a microbiome perspective, recognizing the microbial etiology of PID, especially the role of Chlamydia trachomatis, should inform both clinical practice and public health messaging to improve screening, early diagnosis, and treatment. Enhanced awareness could contribute to reducing infertility rates attributable to PID, particularly in similar populations and settings.

Pelvic Inflammatory Disease (PID)

Pelvic Inflammatory Disease (PID) is a complex interplay between pathogens, immune responses, and microbial communities. As research continues to uncover the microbiome's role in reproductive health, microbiome-targeted interventions (MBTIs) such as probiotics, prebiotics, and transplants are redefining how we prevent and treat PID. This page dives deep into these innovations, offering a glimpse into the future of personalized, biologically informed women’s healthcare.

Female Infertility

Female infertility is a multifactorial condition affecting 10-15% of women of reproductive age, often caused by underlying conditions like Bacterial Vaginosis (BV), PCOS, Endometriosis, and Pelvic Inflammatory Disease (PID). Microbiome-targeted interventions (MBTIs) offer a promising approach to restoring balance, improving fertility outcomes, and addressing root causes.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.